ANI Pharmaceuticals, Inc. (ANIP)
72.29
+0.01
(+0.01%)
USD |
NASDAQ |
Oct 16, 16:00
72.25
-0.04
(-0.06%)
After-Hours: 20:00
ANI Pharmaceuticals Cash from Investing (Quarterly) : -3.054M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.054M |
| March 31, 2026 | -11.32M |
| December 31, 2025 | -1.403M |
| September 30, 2025 | -6.163M |
| June 30, 2025 | -6.909M |
| March 31, 2025 | -19.85M |
| December 31, 2024 | -10.68M |
| September 30, 2024 | -398.52M |
| June 30, 2024 | -4.449M |
| March 31, 2024 | 8.933M |
| December 31, 2023 | -4.779M |
| September 30, 2023 | -4.553M |
| June 30, 2023 | -6.826M |
| March 31, 2023 | -2.353M |
| December 31, 2022 | -3.142M |
| September 30, 2022 | -9.814M |
| June 30, 2022 | -0.604M |
| March 31, 2022 | -2.178M |
| December 31, 2021 | -82.21M |
| September 30, 2021 | -0.583M |
| June 30, 2021 | -21.95M |
| March 31, 2021 | -0.737M |
| December 31, 2020 | -2.119M |
| September 30, 2020 | -5.809M |
| June 30, 2020 | -2.848M |
| Date | Value |
|---|---|
| March 31, 2020 | -57.55M |
| December 31, 2019 | -1.374M |
| September 30, 2019 | -1.932M |
| June 30, 2019 | -3.958M |
| March 31, 2019 | -20.28M |
| December 31, 2018 | -0.407M |
| September 30, 2018 | -18.44M |
| June 30, 2018 | -6.255M |
| March 31, 2018 | -2.278M |
| December 31, 2017 | -50.12M |
| September 30, 2017 | -2.48M |
| June 30, 2017 | -2.304M |
| March 31, 2017 | -53.09M |
| December 31, 2016 | -1.39M |
| September 30, 2016 | -1.089M |
| June 30, 2016 | -66.03M |
| March 31, 2016 | -85.55M |
| December 31, 2015 | -1.105M |
| September 30, 2015 | -26.77M |
| June 30, 2015 | -0.198M |
| March 31, 2015 | -4.612M |
| December 31, 2014 | -0.338M |
| September 30, 2014 | -22.53M |
| June 30, 2014 | -0.253M |
| March 31, 2014 | -12.64M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -3.367M |
| Liquidia Corp. | -12.24M |
| Elanco Animal Health, Inc. | -110.00M |
| Harmony Biosciences Holdings, Inc. | -131.50M |
| Corcept Therapeutics, Inc. | -29.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 56.67M |
| Cash from Financing (Quarterly) | -4.647M |
| Free Cash Flow | 167.52M |
| Free Cash Flow Per Share (Quarterly) | 2.446 |
| Free Cash Flow to Equity (Quarterly) | 56.88M |
| Free Cash Flow to Firm (Quarterly) | 58.61M |
| Free Cash Flow Yield | 10.74% |